CALT - Calliditas releases phase 2 results on head and neck cancer asset setanaxib
2024-05-06 11:52:08 ET
More on Calliditas Therapeutics
- Calliditas Therapeutics AB (publ) (CALT) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Calliditas Therapeutics
- Historical earnings data for Calliditas Therapeutics
- Financial information for Calliditas Therapeutics